{"id":"W4413092622","doi":"10.1016/j.annonc.2025.05.189","title":"176P Tegavivint, a downstream Wnt/β-catenin inhibitor: Interim results from a phase I/II trial in advanced hepatocellular carcinoma (aHCC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Interim; Interim analysis; Internal medicine; Wnt signaling pathway; Regorafenib; Oncology; Clinical trial; Cancer; Colorectal cancer; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009122078,0.001074726,0.00121518,0.0003338445,0.0003028969,0.001100953,0.0005676819,0.001137074,0.006874516],"category_scores_gemma":[0.0006670595,0.0003054095,0.001191556,0.0003269251,0.0005051935,0.0007038145,0.0003650947,0.003048723,0.001621946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007896745,"about_ca_system_score_gemma":0.001081215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001458069,"about_ca_topic_score_gemma":0.004100665,"domain_scores_codex":[0.9997956,0.0000634011,0.00001041875,0.00002845403,0.00002906043,0.00007309164],"domain_scores_gemma":[0.999685,0.00005591063,0.00004354843,0.00002396454,0.00002322743,0.0001683135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3622315,0.01265191,0.007884108,0.002150561,0.002855482,0.0006683381,0.0002393565,0.00518516,0.05492412,0.001595671,0.0442495,0.5053643],"study_design_scores_gemma":[0.6099582,0.2880849,0.02701866,0.0002960639,0.002652609,0.001432758,0.0001720575,0.00359817,0.01903159,0.001986281,0.04565699,0.0001116401],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9405417,0.02125237,0.001847921,0.00638299,0.001010994,0.002012877,0.008259473,0.0006103888,0.01808122],"genre_scores_gemma":[0.9401438,0.01230147,0.004330437,0.005311422,0.0004703046,0.002209517,0.01609999,0.000144321,0.01898879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006874516,"threshold_uncertainty_score":0.0229975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1335508853952117,"score_gpt":0.3804263066116461,"score_spread":0.2468754212164344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}